Ness Ziona, Israel – Aug. 6, 2020 – BiomX Inc. (NYSE: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and live audio webcast on Thursday, Aug. 13, 2020, at 8:00 a.m. EDT to report second quarter 2020 financial results and provide a corporate update. The conference call dial-in numbers are 1-877-407-0724 (U.S.), 1-809-406-247 (Israel) or 1-201-389-0898 (international). The live and archived webcast will be available in the Investors section of the company’s website at www.biomx.com.

 

About BiomX

 

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC), and colorectal cancer (CRC). BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For additional information, please see www.biomx.com.

###

Contacts


Noel Kurdi, BiomX
VP, Investor Relations and Strategy
(646) 241-4400
noelk@biomx.com

 

Media contact:

Rich Allan, Solebury Trout

(646)-378-2958

rallan@soleburytrout.com